Sign in
LKFT Stock Price, Chart, Stats & News
Lakefront Biotherapeutics N.V.
Save
Lakefront Biotherapeutics N.V. (LKFT) does not currently pay a dividend.
1.98B
Market cap
3.43x
Current P/E
344.83x
Forward P/E
LKFT chart
1M
3M
1Y
5Y
Loading chart...
About
Galapagos NV is a biotechnology company that specializes in the discovery and advancement of novel small molecule and antibody-based therapeutics. Its active clinical development programs include drugs like filgotinib and GLP3667, alongside the Toledo program and therapies targeting idiopathic pulmonary fibrosis. The firm was established on June 30, 1999, by co-founders Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es, and maintains its headquarters in Mechelen, Belgium.
Similar securities
Based on sector and market capitalization
Report issue